NuScale Power enters $150M at-the-market offering agreement with Cowen, B. Riley, Canaccord

NUSCALE POWER Corp

ATM offering of up to $150M of Class A common stock under Sales Agreement with Cowen, B. Riley Securities, and Canaccord Genuity.
Sales agents receive commission of up to 3% of gross proceeds; Company provides customary indemnification.
Shares to be sold through NYSE or other trading markets at Company's discretion; no minimum price specified.
Prospectus supplement filed August 9, 2023; registration statement on Form S-3 effective June 8, 2023.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 1.0

NUSCALE POWER Corp entered into Sales Agreement with Cowen and Company, LLC, B. Riley Securities, Inc., Canaccord Genuity LLC valued at up to $150,000,000 (effective 2023-08-09).

Action: entry
Agreement: atm program
Counterparty: Cowen and Company, LLC, B. Riley Securities, Inc., Canaccord Genuity LLC
Value: up to $150,000,000
Effective: 2023-08-09

Exact text from the filing

On August 9, 2023, NuScale Power Corporation (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Cowen and Company, LLC (“Cowen”), B. Riley Securities, Inc. (“B. Riley”) and Canaccord Genuity LLC (“Canaccord”), with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its Class A common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $150,000,000 (the “Shares”) through any of Cowen, B. Riley or Canaccord as its “sales agent.”

View on SEC.gov

Browse all material agreements →

NUSCALE POWER Corp filing history →

Source: SEC EDGAR

accession 0001822966-23-000207

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.